Multiple functions of HMGB1 in cancer

被引:7
|
作者
Lv, Guangyao [1 ]
Yang, Menglin [2 ]
Gai, Keke [1 ]
Jia, Qiong [1 ]
Wang, Zhenzhen [1 ]
Wang, Bin [1 ]
Li, Xueying [3 ]
机构
[1] Binzhou Med Univ Hosp, Dept Pharm, Binzhou, Shandong, Peoples R China
[2] Marine Biomed Res Inst Qingdao, Qual Management Dept, Qingdao, Peoples R China
[3] Binzhou Polytech, Sch Hlth, Binzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
HMGB1; cancer; chemotherapy resistance; autophagy; immunotherapy; GROUP BOX 1; IMMUNOGENIC CELL-DEATH; HMGB1-MEDIATED AUTOPHAGY; PROTEIN HMGB1; ANGIOGENESIS; CHEMOTHERAPY; RESISTANCE; EXPRESSION; PROGRESSION; MIGRATION;
D O I
10.3389/fonc.2024.1384109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High mobility group box 1 (HMGB1) is a nuclear DNA-binding protein with a dual role in cancer, acting as an oncogene and a tumor suppressor. This protein regulates nucleosomal structure, DNA damage repair, and genomic stability within the cell, while also playing a role in immune cell functions. This review comprehensively evaluates the biological and clinical significance of HMGB1 in cancer, including its involvement in cell death and survival, its potential as a therapeutic target and cancer biomarker, and as a prosurvival signal for the remaining cells after exposure to cytotoxic anticancer treatments. We highlight the need for a better understanding of the cellular markers and mechanisms involved in the involvement of HMGB1in cancer, and aim to provide a deeper understanding of its role in cancer progression.
引用
收藏
页数:12
相关论文
共 50 条
  • [11] Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
    Liikanen, Ilkka
    Koski, Anniina
    Merisalo-Soikkeli, Maiju
    Hemminki, Otto
    Oksanen, Minna
    Kairemo, Kalevi
    Joensuu, Timo
    Kanerva, Anna
    Hemminki, Akseli
    ONCOIMMUNOLOGY, 2015, 4 (03): : 1 - 13
  • [12] Radiochemotherapy-induced elevations of plasma HMGB1 levels predict therapeutic responses in cancer patients
    Kroemer, Guido
    Kepp, Oliver
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [13] The redox protein HMGB1 regulates cell death and survival in cancer treatment
    Tang, Daolin
    Lotze, Michael T.
    Zeh, Herbert J.
    Kang, Rui
    AUTOPHAGY, 2010, 6 (08) : 1181 - 1183
  • [14] Paradoxical Role of HMGB1 in Pancreatic Cancer: Tumor Suppressor or Tumor Promoter?
    Cebrian, Maria Jose Garcia
    Bauden, Monika
    Andersson, Roland
    Holdenrieder, Stefan
    Ansari, Daniel
    ANTICANCER RESEARCH, 2016, 36 (09) : 4381 - 4389
  • [15] A pan-cancer analysis of the oncogenic function of HMGB1 in human tumors
    Yang, Hui-min
    Zhao, Xiang-ning
    Li, Xiao-ling
    Wang, Xi
    Pu, Yu
    Wei, Dong-kai
    Li, Zhe
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2024, 40
  • [16] Variation of HMGB1 expression in breast cancer
    Flohr, AM
    Rogalla, P
    Meiboom, M
    Borrmann, L
    Krohn, M
    Thode-Halle, B
    Bullerdiek, J
    ANTICANCER RESEARCH, 2001, 21 (6A) : 3881 - 3885
  • [17] Extracellular HMGB1 interacts with RAGE and promotes chemoresistance in acute leukemia cells
    Lai, Weixin
    Li, Xinyu
    Kong, Qian
    Chen, Han
    Li, Yunyao
    Xu, Lu-Hong
    Fang, Jianpei
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [18] The role of HMGB1 in liver inflammation in obese rats
    Erdal, M.
    Altunkaynak, B. Z.
    Kocaman, A.
    Alkan, I
    Oztas, E.
    BIOTECHNIC & HISTOCHEMISTRY, 2019, 94 (06) : 449 - 458
  • [19] The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
    Suren, Dinc
    Yildirim, Mustafa
    Demirpence, Ozlem
    Kaya, Vildan
    Alikanoglu, Arsenal Sezgin
    Bulbuller, Nurullah
    Yildiz, Mustafa
    Sezer, Cem
    MEDICAL SCIENCE MONITOR, 2014, 20 : 530 - 537
  • [20] HMGB1 knockdown effectively inhibits the progression of rectal cancer by suppressing HMGB1 expression and promoting apoptosis of rectal cancer cells
    Wang, Zhiwei
    Wang, Xiaoyan
    Li, Jiantian
    Yang, Cheng
    Xing, Zhiyuan
    Chen, Ruiyun
    Xu, Fei
    MOLECULAR MEDICINE REPORTS, 2016, 14 (01) : 1026 - 1032